Effective with dates of service on and after October 1, 2020, and in accordance with the IngenioRx Pharmacy and Therapeutics (P&T) process, Anthem Blue Cross (Anthem) will update its drug lists that support commercial health plans.

Updates include changes to drug tiers and the removal of medications from the formulary.  The changes apply for only new prescriptions; members with existing prescriptions for these medications will not be impacted.

Please note, this update does not apply to the Select Drug List and does not affect Medicaid and Medicare plans.

To ensure a smooth member transition and minimize costs, providers should review these changes and consider prescribing medications on formulary, if appropriate. 

View a summary of changes here.  

IngenioRx, Inc. is an independent company providing pharmacy benefit management services on behalf of Anthem.



Featured In:
September 2020 Anthem Blue Cross Provider News - California